Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mackenzie Wehner

Mackenzie R. Wehner MD, MPhil

Assistant Professor of Dermatology and Assistant Professor of Health Services Research, MD Anderson Cancer Center, Houston, Texas

Mackenzie Wehner, MD, MPhil, is currently an Assistant Professor in Health Services Research and in Dermatology at MD Anderson Cancer Center. She received a BS in Molecular Biophysics and Biochemistry from Yale University, an MD from Stanford University, and a Master’s in epidemiology at the University of Cambridge. During medical training she was a Doris Duke Charitable Foundation Research Fellow in skin cancer epidemiology at UCSF. She completed an NIH-funded physician-scientist track dermatology residency program at the University of Pennsylvania.

Dr. Wehner is a Cancer Prevention Research Institute of Texas (CPRIT) Scholar in Cancer Research, as a recipient of the CPRIT recruitment grant for first-time faculty. She has first-author publications in Lancet, BMJ, Lancet Oncology, and JAMA Oncology, among others. Dr. Wehner's work investigating the impact of indoor tanning has been featured in the Surgeon General’s Call to Action to Prevent Skin Cancer (2014), as well as being the primary source for currently circulating World Health Organization indoor tanning prevention materials. Additionally, Dr. Wehner has expanded the understanding of skin cancer phenotypes in basal cell carcinoma and squamous cell carcinoma, work that contributed to screening recommendations for patients with prior skin cancers in the American Academy of Dermatology guidelines (2018).